Home > PJ (current issue) > Letters | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 268 No 7202 p837-838
15 June 2002

This page
Reprint
Photocopy

   

PDF* 55K

Letters

   Concordance
   Computer systems
   Product identification
   Council elections
   The Council


Letters to the Editor

  * PDF files on PJ Online require Acrobat Reader 4 or later.

Product identification

Time to work together

From Mr A. Gledhill, MRPharmS

I would like to request that all suppliers of drug database information software work together to use a common generic code which will identify a particular product irrespective of pack size or manufacturer. An example would be "Atenolol tablets 100mg".

Such a code would be useful in a variety of ways. If printed as a bar code on patient packs it could be used to scan issues and stock returns to prescribing or stock control systems. It could be used by authorised hospital staff to scan patients' own medicines into the hospital computer system on admission. It could be used to link up GP/community/hospital prescribing/dispensing software. It could be used to update regional drug contract catalogue data, etc. I understand some of the software suppliers who would need to work together are AAH, ASC, Drug Tariff, EMIS, First Databank, NDC Health, Pharmed, the Prescription Pricing Authority and UniChem.

No doubt some of these parties are already considering using such a common code and I would suggest using the freely available eDrugID code from First Databank (www.firstdatabank.co.uk) as a means to move forward quickly.

As well as increasing patient safety it would simplify and make the prescribing and dispensing process far more efficient.

Andrew Gledhill
Burnley, Lancashire

 

ROBIN GLASSPOOLE, business development manager, First DataBank Europe Ltd, comments:

The importance of having a nationally accepted drug identifier has been appreciated for some time. Previous initiatives have failed to deliver an acceptable number. However, there is now growing expectation that two Government projects will provide a satisfactory solution. It is important that pharmacists are aware of these two projects because they will be crucial for the success of many of the information technology developments that are expected to revolutionise health care practice in the near future, eg, electronic transfer of prescriptions pilots.

First, there is the Primary Care Drug Dictionary (PCDD) which has been initiated by the Department of Health and the Prescription Pricing Authority. Second, the NHS Information Authority is running a project known as the United Kingdom Clinical Products Reference Source (UKCPRS). The two projects have been working closely together to give a "federal" approach in providing a stable drug identifier which will address the issues highlighted by Mr Gledhill. The PCDD is expected to be fully populated by the first quarter of 2003 with the UKCPRS being available from 2004. Further information can be found about the PCDD and the UKCPRS.

The combined solution will have relevance to both primary and secondary care. The drug dictionaries have been designed with the intention that they can meet the varied working needs of different health care practitioners in prescribing, dispensing and contracting scenarios, etc. Many of the software suppliers mentioned have been involved in both the design, use, case testing and implementation discussions. Their considerable experience has helped with the development of these projects.

First DataBank Europe decided to release eDrugID in March 2001 to meet the immediate need of providing a standard textual drug descriptor and a stable set of drug identifiers. At the time we saw this as a suitable mechanism for providing a standard that anyone could freely use while the DoH initiatives were being developed. We foresee that the need for eDrugID will disappear once the PCDD and UKCPRS projects are delivered.

Send your letter to The Editor

Previous Topic (Computer systems)
Next Topic (Council elections)

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal